{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:31:43Z","timestamp":1781620303948,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K07470"],"award-info":[{"award-number":["JP21K07470"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K07508"],"award-info":[{"award-number":["JP22K07508"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["Fujita Mind-Brain Research"],"award-info":[{"award-number":["Fujita Mind-Brain Research"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["Innovation Center for Drug Generation (Fujita Mind-BRIDGe) of the Japan\u2019s Peak Research Universities (J-PEAKS) Program"],"award-info":[{"award-number":["Innovation Center for Drug Generation (Fujita Mind-BRIDGe) of the Japan\u2019s Peak Research Universities (J-PEAKS) Program"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00702-025-03022-x","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:13:42Z","timestamp":1758600822000},"page":"485-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation"],"prefix":"10.1007","volume":"133","author":[{"given":"Toshiki","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Ohdake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryunosuke","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"3022_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496\u2013503","journal-title":"Neurology"},{"key":"3022_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/mds.20450","volume":"20","author":"LM Benrud-Larson","year":"2005","unstructured":"Benrud-Larson LM, Sandroni P, Schrag A, Low PA (2005) Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord 20:951\u2013957","journal-title":"Mov Disord"},{"key":"3022_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/neup.13021","author":"R Gabdulkhaev","year":"2024","unstructured":"Gabdulkhaev R, Shimizu H, Kanazawa M et al (2024) Blood-brain barrier dysfunction in multiple system atrophy: a human postmortem study. Neuropathology. https:\/\/doi.org\/10.1111\/neup.13021","journal-title":"Neuropathology"},{"key":"3022_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"3022_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0071-x","volume":"11","author":"A Heslegrave","year":"2016","unstructured":"Heslegrave A, Heywood W, Paterson R et al (2016) Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease. Mol Neurodegener 11:3","journal-title":"Mol Neurodegener"},{"key":"3022_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"3022_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-018-0612-3","volume":"6","author":"M H\u00fcttenrauch","year":"2018","unstructured":"H\u00fcttenrauch M, Ogorek I, Klafki H et al (2018) Glycoprotein NMB: a novel Alzheimer\u2019s disease associated marker expressed in a subset of activated microglia. Acta Neuropathol Commun 6:108","journal-title":"Acta Neuropathol Commun"},{"key":"3022_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.28814","volume":"37","author":"A Jucaite","year":"2022","unstructured":"Jucaite A, Csel\u00e9nyi Z, Kreisl WC et al (2022) Glia imaging differentiates multiple system atrophy from Parkinson\u2019s disease: a positron emission tomography study with [11 C]PBR28 and machine learning analysis. Mov Disord 37:119\u2013129","journal-title":"Mov Disord"},{"key":"3022_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","volume":"89","author":"S Koga","year":"2018","unstructured":"Koga S, Dickson DW (2018) Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. J Neurol Neurosurg Psychiatry 89:175\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3022_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N et al (2021) Neuropathology and molecular diagnosis of synucleinopathies. Mol Neurodegener 16:83","journal-title":"Mol Neurodegener"},{"key":"3022_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12747-w","volume":"272","author":"F Maass","year":"2024","unstructured":"Maass F, Canaslan S, van Riesen C et al (2024) Myelin basic protein and TREM2 quantification in the CSF of patients with multiple system atrophy and other Parkinsonian conditions. J Neurol 272:52","journal-title":"J Neurol"},{"key":"3022_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.753210","volume":"13","author":"M Mo","year":"2021","unstructured":"Mo M, Tang Y, Wei L et al (2021) Soluble triggering receptor expressed on myeloid cells 2 from cerebrospinal fluid in sleep disorders related to Parkinson\u2019s disease. Front Aging Neurosci 13:753210","journal-title":"Front Aging Neurosci"},{"key":"3022_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110020","volume":"257","author":"J Pocock","year":"2024","unstructured":"Pocock J, Vasilopoulou F, Svensson E, Cosker K (2024) Microglia and TREM2. Neuropharmacology 257:110020","journal-title":"Neuropharmacology"},{"key":"3022_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease: MDS-PD clinical diagnostic criteria. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"3022_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674739","volume":"12","author":"M Saade","year":"2021","unstructured":"Saade M, Araujo de Souza G, Scavone C, Kinoshita PF (2021) The role of GPNMB in inflammation. Front Immunol 12:674739","journal-title":"Front Immunol"},{"key":"3022_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mds.27992","volume":"35","author":"J S\u00e1nchez-Ruiz de Gordoa","year":"2020","unstructured":"S\u00e1nchez-Ruiz de Gordoa J, Erro ME, Vicu\u00f1a-Urriza J et al (2020) Microglia-related gene triggering receptor expressed in myeloid cells 2 (TREM2) is upregulated in the substantia nigra of progressive supranuclear palsy. Mov Disord 35:885\u2013890","journal-title":"Mov Disord"},{"key":"3022_CR17","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1002\/mds.28738","volume":"36","author":"I Schulz","year":"2021","unstructured":"Schulz I, Kruse N, Gera RG et al (2021) Systematic assessment of 10 biomarker candidates focusing on \u03b1-synuclein-related disorders. Mov Disord 36:2874\u20132887","journal-title":"Mov Disord"},{"key":"3022_CR18","doi-asserted-by":"publisher","first-page":"e2460","DOI":"10.1212\/WNL.0000000000207905","volume":"101","author":"H Sekiya","year":"2023","unstructured":"Sekiya H, Koga S, Murakami A et al (2023) Validation study of the MDS criteria for the diagnosis of multiple system atrophy in the Mayo Clinic brain bank. Neurology 101:e2460\u2013e2471","journal-title":"Neurology"},{"key":"3022_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Su\u00e1rez-Calvet","year":"2019","unstructured":"Su\u00e1rez-Calvet M, Morenas-Rodr\u00edguez E, Kleinberger G et al (2019) Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegener 14:1","journal-title":"Mol Neurodegener"},{"key":"3022_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/mds.20478","volume":"20","author":"Y Tsuboi","year":"2005","unstructured":"Tsuboi Y, Josephs KA, Boeve BF et al (2005) Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 20:982\u2013988","journal-title":"Mov Disord"},{"key":"3022_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14802\/jmd.22082","volume":"16","author":"H Watanabe","year":"2023","unstructured":"Watanabe H, Shima S, Mizutani Y et al (2023) Multiple system atrophy: advances in diagnosis and therapy. J Mov Disord 16:13\u201321","journal-title":"J Mov Disord"},{"key":"3022_CR22","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37:1131\u20131148","journal-title":"Mov Disord"},{"key":"3022_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ane.12804","volume":"137","author":"L-Y Zhang","year":"2018","unstructured":"Zhang L-Y, Cao B, Zou Y-T et al (2018) Depression and anxiety in multiple system atrophy. Acta Neurol Scand 137:33\u201337","journal-title":"Acta Neurol Scand"},{"key":"3022_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mds.28847","volume":"37","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cao B, Hou Y et al (2022) Neurofilament light chain predicts disease severity and progression in multiple system atrophy. Mov Disord 37:421\u2013426","journal-title":"Mov Disord"},{"key":"3022_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136300","volume":"767","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Liu Y, Li X et al (2022) GPNMB mitigates Alzheimer\u2019s disease and enhances autophagy via suppressing the mTOR signal. Neurosci Lett 767:136300","journal-title":"Neurosci Lett"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03022-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:14:28Z","timestamp":1773846868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03022-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3022"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03022-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}